 Angela Czaja
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 8 | 2020 | 208 | 2.310 |
Why?
| | Critical Illness | 6 | 2021 | 719 | 1.800 |
Why?
| | Arrhythmias, Cardiac | 3 | 2020 | 313 | 1.680 |
Why?
| | Off-Label Use | 3 | 2023 | 56 | 1.170 |
Why?
| | Patient Readmission | 4 | 2014 | 694 | 1.100 |
Why?
| | Medicine | 3 | 2023 | 112 | 1.080 |
Why?
| | Palliative Care | 2 | 2021 | 664 | 0.970 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 95 | 0.920 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1280 | 0.860 |
Why?
| | Child | 32 | 2023 | 20014 | 0.830 |
Why?
| | Central Venous Catheters | 1 | 2022 | 43 | 0.810 |
Why?
| | Critical Care | 5 | 2022 | 563 | 0.800 |
Why?
| | Simulation Training | 1 | 2022 | 72 | 0.760 |
Why?
| | International Classification of Diseases | 2 | 2020 | 131 | 0.740 |
Why?
| | Quality Indicators, Health Care | 2 | 2014 | 318 | 0.730 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 2018 | 9 | 0.620 |
Why?
| | Child, Preschool | 17 | 2021 | 9938 | 0.620 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 36 | 0.610 |
Why?
| | Cannula | 1 | 2018 | 26 | 0.610 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2018 | 70 | 0.600 |
Why?
| | Healthcare Disparities | 2 | 2014 | 515 | 0.600 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 78 | 0.580 |
Why?
| | Noninvasive Ventilation | 1 | 2017 | 36 | 0.570 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2018 | 144 | 0.560 |
Why?
| | Heart Arrest | 1 | 2020 | 312 | 0.530 |
Why?
| | Enteral Nutrition | 1 | 2017 | 175 | 0.530 |
Why?
| | Retrospective Studies | 14 | 2022 | 13708 | 0.490 |
Why?
| | Infant | 15 | 2020 | 8625 | 0.490 |
Why?
| | Physicians | 1 | 2023 | 836 | 0.480 |
Why?
| | Respiratory Insufficiency | 1 | 2018 | 309 | 0.470 |
Why?
| | Databases, Factual | 5 | 2020 | 1298 | 0.470 |
Why?
| | Heart Diseases | 2 | 2018 | 364 | 0.450 |
Why?
| | Pediatrics | 2 | 2017 | 1046 | 0.400 |
Why?
| | Electronic Health Records | 1 | 2018 | 875 | 0.380 |
Why?
| | Pediatric Nursing | 1 | 2011 | 44 | 0.370 |
Why?
| | Humans | 37 | 2023 | 125131 | 0.370 |
Why?
| | Antidepressive Agents | 1 | 2012 | 202 | 0.360 |
Why?
| | Length of Stay | 3 | 2021 | 1077 | 0.340 |
Why?
| | Sepsis | 2 | 2022 | 563 | 0.340 |
Why?
| | Fellowships and Scholarships | 3 | 2022 | 270 | 0.340 |
Why?
| | Infant, Newborn | 8 | 2023 | 5456 | 0.340 |
Why?
| | Thoracic Surgery | 1 | 2011 | 127 | 0.330 |
Why?
| | Adolescent | 16 | 2023 | 19411 | 0.330 |
Why?
| | Hospitals, Pediatric | 3 | 2021 | 517 | 0.330 |
Why?
| | Nursing Staff, Hospital | 1 | 2011 | 152 | 0.330 |
Why?
| | Hospital Mortality | 4 | 2021 | 897 | 0.320 |
Why?
| | Dexmedetomidine | 1 | 2009 | 52 | 0.320 |
Why?
| | Education, Medical, Graduate | 2 | 2023 | 441 | 0.300 |
Why?
| | Emergencies | 1 | 2009 | 160 | 0.300 |
Why?
| | Hypnotics and Sedatives | 1 | 2009 | 149 | 0.300 |
Why?
| | Cohort Studies | 6 | 2020 | 5348 | 0.280 |
Why?
| | United States | 10 | 2022 | 13613 | 0.270 |
Why?
| | Female | 16 | 2021 | 64889 | 0.250 |
Why?
| | Clinical Competence | 2 | 2022 | 1013 | 0.250 |
Why?
| | Male | 17 | 2021 | 60792 | 0.250 |
Why?
| | Risk Factors | 7 | 2020 | 9549 | 0.240 |
Why?
| | Age Factors | 3 | 2020 | 3152 | 0.230 |
Why?
| | Consensus | 2 | 2023 | 577 | 0.230 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 187 | 0.230 |
Why?
| | Logistic Models | 3 | 2020 | 2040 | 0.220 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2011 | 801 | 0.210 |
Why?
| | Delphi Technique | 1 | 2023 | 179 | 0.210 |
Why?
| | Intubation, Intratracheal | 2 | 2018 | 240 | 0.210 |
Why?
| | Faculty | 1 | 2023 | 142 | 0.200 |
Why?
| | Wounds and Injuries | 1 | 2009 | 833 | 0.190 |
Why?
| | Central Nervous System Stimulants | 1 | 2023 | 144 | 0.190 |
Why?
| | Prescription Drugs | 1 | 2023 | 117 | 0.190 |
Why?
| | Ultrasonography, Interventional | 1 | 2022 | 156 | 0.190 |
Why?
| | Femoral Vein | 1 | 2020 | 29 | 0.180 |
Why?
| | Young Adult | 6 | 2020 | 11384 | 0.180 |
Why?
| | Citalopram | 1 | 2020 | 28 | 0.180 |
Why?
| | Washington | 2 | 2011 | 138 | 0.170 |
Why?
| | Shock, Septic | 1 | 2022 | 217 | 0.170 |
Why?
| | Risk Assessment | 3 | 2017 | 3274 | 0.170 |
Why?
| | Health Status Indicators | 2 | 2011 | 169 | 0.170 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2020 | 80 | 0.160 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 745 | 0.160 |
Why?
| | Adult | 8 | 2021 | 33167 | 0.150 |
Why?
| | Coronary Care Units | 1 | 2018 | 16 | 0.150 |
Why?
| | Curriculum | 2 | 2022 | 943 | 0.150 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2018 | 70 | 0.150 |
Why?
| | Proportional Hazards Models | 2 | 2013 | 1191 | 0.150 |
Why?
| | Odds Ratio | 1 | 2020 | 1050 | 0.140 |
Why?
| | Faculty, Medical | 1 | 2020 | 265 | 0.140 |
Why?
| | Family Practice | 1 | 2021 | 488 | 0.140 |
Why?
| | Delirium | 1 | 2018 | 74 | 0.140 |
Why?
| | Hospitalization | 2 | 2020 | 1960 | 0.140 |
Why?
| | Intensive Care Units | 1 | 2021 | 663 | 0.140 |
Why?
| | Administration, Inhalation | 1 | 2018 | 667 | 0.140 |
Why?
| | Pharmacoepidemiology | 1 | 2016 | 22 | 0.130 |
Why?
| | Epidemiologic Research Design | 1 | 2016 | 32 | 0.130 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2020 | 402 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2021 | 705 | 0.130 |
Why?
| | Internship and Residency | 2 | 2022 | 1083 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 247 | 0.130 |
Why?
| | Comorbidity | 2 | 2011 | 1635 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 365 | 0.110 |
Why?
| | Cross-Sectional Studies | 4 | 2023 | 4854 | 0.110 |
Why?
| | Insurance Claim Review | 1 | 2013 | 70 | 0.110 |
Why?
| | Needs Assessment | 3 | 2022 | 358 | 0.110 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 171 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2020 | 3326 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2018 | 3047 | 0.100 |
Why?
| | Algorithms | 1 | 2020 | 1618 | 0.100 |
Why?
| | Patient Discharge | 2 | 2022 | 857 | 0.100 |
Why?
| | Drug Approval | 1 | 2012 | 82 | 0.100 |
Why?
| | Time Factors | 2 | 2013 | 6780 | 0.100 |
Why?
| | Patient Admission | 1 | 2013 | 198 | 0.100 |
Why?
| | Hospital Units | 1 | 2011 | 25 | 0.100 |
Why?
| | Nursing Methodology Research | 1 | 2011 | 53 | 0.100 |
Why?
| | Managed Care Programs | 1 | 2012 | 156 | 0.090 |
Why?
| | Cardiac Output | 1 | 2011 | 154 | 0.090 |
Why?
| | Incidence | 2 | 2018 | 2578 | 0.090 |
Why?
| | Biomedical Research | 1 | 2017 | 641 | 0.090 |
Why?
| | Anesthetics, Intravenous | 1 | 2010 | 35 | 0.090 |
Why?
| | Ventilator Weaning | 1 | 2010 | 34 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2018 | 1561 | 0.090 |
Why?
| | Risk Adjustment | 1 | 2011 | 85 | 0.090 |
Why?
| | Risk | 1 | 2013 | 896 | 0.090 |
Why?
| | Propofol | 1 | 2010 | 51 | 0.090 |
Why?
| | Aged | 3 | 2021 | 20859 | 0.090 |
Why?
| | Colorado | 2 | 2017 | 4471 | 0.090 |
Why?
| | Device Removal | 1 | 2010 | 116 | 0.080 |
Why?
| | Prognosis | 3 | 2018 | 3616 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 664 | 0.080 |
Why?
| | Postoperative Care | 1 | 2010 | 245 | 0.080 |
Why?
| | Cardiomyopathies | 1 | 2011 | 314 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2021 | 5061 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2013 | 9790 | 0.070 |
Why?
| | Chronic Disease | 1 | 2013 | 1684 | 0.070 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 594 | 0.070 |
Why?
| | Cause of Death | 1 | 2009 | 394 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2013 | 4824 | 0.070 |
Why?
| | Prospective Studies | 4 | 2022 | 6818 | 0.070 |
Why?
| | Ibuprofen | 1 | 2007 | 76 | 0.070 |
Why?
| | Burnout, Professional | 1 | 2011 | 340 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2669 | 0.060 |
Why?
| | Heart Transplantation | 1 | 2011 | 689 | 0.060 |
Why?
| | Anxiety | 1 | 2011 | 924 | 0.060 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 304 | 0.060 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2007 | 259 | 0.060 |
Why?
| | Suicide, Attempted | 1 | 2007 | 335 | 0.060 |
Why?
| | Pandemics | 2 | 2023 | 1434 | 0.060 |
Why?
| | Heart Defects, Congenital | 1 | 2010 | 746 | 0.060 |
Why?
| | Middle Aged | 3 | 2021 | 29112 | 0.050 |
Why?
| | Depression | 1 | 2011 | 1236 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2023 | 58 | 0.050 |
Why?
| | Competency-Based Education | 1 | 2022 | 69 | 0.050 |
Why?
| | Obesity | 1 | 2015 | 2805 | 0.050 |
Why?
| | Health Resources | 1 | 2022 | 137 | 0.050 |
Why?
| | Aftercare | 1 | 2022 | 208 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2011 | 1880 | 0.040 |
Why?
| | Certification | 1 | 2020 | 113 | 0.040 |
Why?
| | Survivors | 1 | 2022 | 460 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2009 | 6936 | 0.040 |
Why?
| | Teaching | 1 | 2020 | 245 | 0.040 |
Why?
| | Qualitative Research | 1 | 2022 | 1021 | 0.040 |
Why?
| | Stroke Volume | 1 | 2020 | 570 | 0.030 |
Why?
| | Echocardiography | 1 | 2020 | 609 | 0.030 |
Why?
| | Ultrasonography | 1 | 2020 | 757 | 0.030 |
Why?
| | International Agencies | 1 | 2016 | 30 | 0.030 |
Why?
| | Sample Size | 1 | 2016 | 138 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2020 | 554 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2015 | 25 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 870 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2015 | 274 | 0.030 |
Why?
| | Information Dissemination | 1 | 2015 | 229 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2015 | 188 | 0.030 |
Why?
| | Body Weight | 1 | 2015 | 959 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2011 | 290 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 1047 | 0.020 |
Why?
| | Pilot Projects | 1 | 2011 | 1530 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2026 | 0.020 |
Why?
|
|
Czaja's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|